Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05288699 · ClinicalTrials.gov registry record · NA

Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety

A NA study of Anxiety and Alcohol Abuse, sponsored by Michael J. Zvolensky, Ph.D..

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05288699 is a NA study of Anxiety and Alcohol Abuse that is actively recruiting participants, run by Michael J. Zvolensky, Ph.D.. The registered enrollment target is 50 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05288699, a NA study of Anxiety and Alcohol Abuse, is actively recruiting participants, sponsored by Michael J. Zvolensky, Ph.D..

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to develop and examine a culturally adapted, brief, integrated, Spanish language mobile health application for the Android platform, optimized to deliver a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Latinx hazardous drinkers with clinical anxiety.

Conditions Studied

Interventions

  • BEHAVIORAL Aliento

Study Locations (1)

Texas

  • RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity - Houston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-11-04
Est. Completion 2025-04-30
Phase NA

Sponsor

Michael J. Zvolensky, Ph.D.

1 total trials

What the Registry Record Tells You About NCT05288699

The ClinicalTrials.gov registry entry for NCT05288699 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower). The listed sponsor is Michael J. Zvolensky, Ph.D., which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Aliento is the first listed.

NCT05288699 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05288699 about?

NCT05288699 is a clinical study titled "Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety". The purpose of this study is to develop and examine a culturally adapted, brief, integrated, Spanish language mobile health application for the Android platform, optimized to deliver a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelat...

What is the current status of trial NCT05288699?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-11-04. Estimated completion is 2025-04-30.

What conditions does trial NCT05288699 study?

This clinical trial studies the following conditions: Anxiety, Alcohol Abuse.

What interventions are being tested in trial NCT05288699?

The interventions under investigation include: Aliento (BEHAVIORAL).

Who is sponsoring clinical trial NCT05288699?

This trial is sponsored by Michael J. Zvolensky, Ph.D., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05288699 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.